Prediagnostic plasma proteomics profile for hepatocellular carcinoma.

Xinyuan ZhangLonggang ZhaoLong H NgoSimon T DillonXuesong GuMichelle LaiTracey G SimonAndrew T ChanEdward L GiovannucciTowia A LibermannXuehong Zhang

Published in: Journal of the National Cancer Institute (2024)

However, the limited number of hepatocellular carcinoma patients in the cohorts necessitates caution in interpreting our findings, emphasizing the need for further validation in high-risk populations.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported
genetic diversity